View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

About ZOMETA: defend against SREs across a broad range of tumour types

About ZOMETA
Prostate Cancer
Dose ZOMETA every 3 to 4 weeks

Page

1 2 3 4

Clinical data support the continued dosing of ZOMETA^®

ZOMETA benefits remain consistent for up to 24 months¹⁶

Efficacy of ZOMETA vs placebo: percentage of prostate cancer patients with >1 SRE¹⁶

In a core study, the benefits of ZOMETA in protecting patients from SREs were sustained through 24 months¹⁶
- — At the 24-month mark, ZOMETA provided a 53% relative reduction in the risk of skeletal complications

Achieve maximum efficacy—treat with ZOMETA 4 mg every 3 to 4 weeks

Page

1 2 3 4

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Clinical data support the continued dosing of ZOMETA®

ZOMETA benefits remain consistent for up to 24 months16

Achieve maximum efficacy—treat with ZOMETA 4 mg every 3 to 4 weeks

Clinical data support the continued dosing of ZOMETA^®

ZOMETA benefits remain consistent for up to 24 months¹⁶